We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
Cap. Flow
+$138M
Cap. Flow %
3.13%
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96

Sector Composition

Rank Sector Weight
1 Financials 4.64%
2 Technology 4.52%
3 Healthcare 4.42%
4 Consumer Staples 4.24%
5 Industrials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSD icon
1601
Invesco S&P Spin-Off ETF
CSD
$229M
-9,848
Closed -$379K
EFX icon
1602
Equifax
EFX
$21.4B
-1,836
Closed -$204K
EPAM icon
1603
EPAM Systems
EPAM
$5.14B
-2,723
Closed -$214K
FAB icon
1604
First Trust Multi Cap Value AlphaDEX Fund
FAB
$177M
-6,748
Closed -$275K
FDT icon
1605
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.3B
-7,512
Closed -$350K
FFTY icon
1606
CapForce IBD 50 ETF
FFTY
$79.8M
-19,290
Closed -$428K
FJP icon
1607
First Trust Japan AlphaDEX Fund
FJP
$258M
-5,783
Closed -$273K
FRI icon
1608
First Trust S&P REIT Index Fund
FRI
$200M
-11,643
Closed -$257K
FTDS icon
1609
First Trust Dividend Strength ETF
FTDS
$39.7M
-8,737
Closed -$212K
GBX icon
1610
The Greenbrier Companies
GBX
$1.43B
-6,521
Closed -$213K
GUT
1611
Gabelli Utility Trust
GUT
$572M
-10,345
Closed -$57K
HCSG icon
1612
Healthcare Services Group
HCSG
$1.46B
-8,624
Closed -$301K
HEEM icon
1613
iShares Currency Hedged MSCI Emerging Markets
HEEM
$287M
-86,100
Closed -$1.72M
HRB icon
1614
H&R Block
HRB
$5.87B
-17,443
Closed -$581K
IAK icon
1615
iShares US Insurance ETF
IAK
$543M
-5,690
Closed -$291K
IGHG icon
1616
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
-3,438
Closed -$252K
INFY icon
1617
Infosys
INFY
$51.5B
-22,842
Closed -$191K
ING icon
1618
ING
ING
$101B
-10,442
Closed -$141K
IXP icon
1619
iShares Global Comm Services ETF
IXP
$569M
-3,644
Closed -$211K
JAZZ icon
1620
Jazz Pharmaceuticals
JAZZ
$16.2B
-1,498
Closed -$211K
KBE icon
1621
State Street SPDR S&P Bank ETF
KBE
$1.73B
-5,999
Closed -$203K
LEMB icon
1622
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$721M
-5,900
Closed -$238K
LNC icon
1623
Lincoln National
LNC
$8.59B
-4,980
Closed -$250K
MAS icon
1624
Masco
MAS
$14.9B
-8,886
Closed -$251K
MNA icon
1625
IQ ARB Merger Arbitrage ETF
MNA
$253M
-23,917
Closed -$671K

Similar funds

Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
  • Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
  • Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
  • Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
  • Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.